Cyr61 and YB-1 are novel interacting partners of uPAR and elevate the malignancy of triple-negative breast cancer

The triple-negative breast cancer (TNBC) is a very aggressive tumor type often occurring in young women and is associated with a bad prognosis for the patients. TNBC lacks established targets for breast cancer therapy, such as the estrogen receptor (ER), progesterone receptor (PR) and the human epid...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Oncotarget
Main Authors: Huber, Michaela C., Falkenberg, Natalie, Hauck, Stefanie M., Priller, Markus, Braselmann, Herbert, Feuchtinger, Annette, Walch, Axel, Schmitt, Manfred, Aubele, Michaela
Formato: Artigo
Idioma:Inglês
Publicado em: Impact Journals LLC 2016
Assuntos:
Research Paper
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5190079/
https://ncbi.nlm.nih.gov/pubmed/27286449
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/oncotarget.9853
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados